What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q2 2018?

115 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 113,177,462
Total 13F shares: 31,601,829
Share change: +10,833,752
Total reported value: $299,901,220
Put/Call ratio: 101%
Price per share: $9.49
Number of holders: 115
Value change: +$126,057,321
Number of buys: 92
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Boxer Capital, LLC	13F	Company	2.8%	3,186,000	$13,923,000	—	31 Mar 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.8%	2,029,396	$8,868,000	—	31 Mar 2018	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.4%	1,628,751	$7,118,000	—	31 Mar 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	1.4%	1,592,416	$6,959,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	1.3%	1,513,707	$6,614,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.2%	1,399,370	$6,115,000	—	31 Mar 2018	13F
Sio Capital Management, LLC	13F	Company	1.1%	1,276,845	$5,580,000	—	31 Mar 2018	13F
Opaleye Management Inc.	13F	Company	0.97%	1,100,800	$4,810,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.74%	832,500	$3,638,000	—	31 Mar 2018	13F
Polar Capital LLP	13F	Company	0.66%	750,000	$3,278,000	—	31 Mar 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.54%	605,794	$2,647,000	—	31 Mar 2018	13F
Park West Asset Management LLC	13F	Company	0.44%	500,000	$2,185,000	—	31 Mar 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.37%	418,753	$1,829,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	0.33%	376,289	$1,645,000	—	31 Mar 2018	13F
Iguana Healthcare Management, LLC	13F	Company	0.33%	375,000	$1,639,000	—	31 Mar 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.28%	315,587	$1,379,000	—	31 Mar 2018	13F
Informed Momentum Co LLC	13F	Company	0.28%	315,001	$1,377,000	—	31 Mar 2018	13F
David M. Knott	13F	Individual	0.21%	242,000	$1,058,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	234,314	$1,023,000	—	31 Mar 2018	13F
Global IMC LLC	13F	Company	0.19%	212,545	$929,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.19%	211,429	$924,000	—	31 Mar 2018	13F
Walleye Trading LLC	13F	Company	0.17%	187,096	$818,000	—	31 Mar 2018	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.15%	174,870	$764,000	—	31 Mar 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.13%	146,149	$639,000	—	31 Mar 2018	13F
Endurant Capital Management LP	13F	Company	0.11%	119,100	$520,000	—	31 Mar 2018	13F
Creative Planning	13F	Company	0.08%	88,140	$385,000	—	31 Mar 2018	13F
Tibra Equities Europe Ltd	13F	Company	0.08%	87,791	$384,000	—	31 Mar 2018	13F
Cornerstone Capital, Inc.	13F	Company	0.08%	86,650	$379,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.07%	78,953	$345,000	—	31 Mar 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.06%	71,096	$311,000	—	31 Mar 2018	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.06%	70,000	$305,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.06%	67,450	$294,000	—	31 Mar 2018	13F
Trexquant Investment LP	13F	Company	0.06%	64,413	$281,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.06%	63,329	$277,000	—	31 Mar 2018	13F
Employees Retirement System of Texas	13F	Company	0.05%	62,000	$271,000	—	31 Mar 2018	13F
Laurion Capital Management LP	13F	Company	0.04%	49,986	$218,000	—	31 Mar 2018	13F
Alpine Global Management, LLC	13F	Company	0.04%	40,000	$175,000	—	31 Mar 2018	13F
Granite Investment Partners, LLC	13F	Company	0.03%	32,068	$140,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.03%	31,900	$140,000	—	31 Mar 2018	13F
GROUP ONE TRADING LLC	13F	Company	0.03%	28,959	$127,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.02%	25,298	$110,000	—	31 Mar 2018	13F
Jefferies Group LLC	13F	Company	0.02%	20,300	$89,000	—	31 Mar 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	18,800	$82,000	—	31 Mar 2018	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.02%	18,407	$80,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	16,276	$71,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	14,975	$65,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.01%	14,673	$64,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.01%	12,877	$56,000	—	31 Mar 2018	13F
Iron Gate Global Advisors LLC	13F	Company	0.01%	12,048	$53,000	—	31 Mar 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.01%	11,988	$52,000	—	31 Mar 2018	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q2 2018

As of 30 Jun 2018, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,601,829 shares. The largest 10 holders included venBio Select Advisor LLC, BOXER CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ArrowMark Colorado Holdings LLC, Opaleye Management Inc., SPHERA FUNDS MANAGEMENT LTD., ACUTA CAPITAL PARTNERS, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 115 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

115

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.